Stage IIIC Cutaneous Melanoma AJCC v7 Active Not Recruiting Phase 1 Trials for Romidepsin (DB06176)

IndicationStatusPhase
DBCOND0091049 (Stage IIIC Cutaneous Melanoma AJCC v7)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01638533Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionTreatment